Basit öğe kaydını göster

dc.contributor.authorKone-Paut, Isabelle
dc.contributor.authorDarce-Bello, Martha
dc.contributor.authorShahram, Farahd
dc.contributor.authorGattorno, Marco
dc.contributor.authorCimaz, Rolando
dc.contributor.authorOzen, Seza
dc.contributor.authorCantarini, Luca
dc.contributor.authorTugal-Tutktun, Ilknur
dc.contributor.authorAssaad-Khalil, Samir
dc.contributor.authorHofer, Michael
dc.contributor.authorKuemmerle-Deschner, Jasmin
dc.contributor.authorBenamour, Saida
dc.contributor.authorAl Mayouf, Souleymane
dc.contributor.authorPajot, Christine
dc.contributor.authorAnton, Jordi
dc.contributor.authorFaye, Albert
dc.contributor.authorBono, Wafa
dc.contributor.authorNielsen, Susan
dc.contributor.authorLetierce, Alexia
dc.contributor.authorTran, Tu-Anh
dc.date.accessioned2019-12-10T10:50:44Z
dc.date.available2019-12-10T10:50:44Z
dc.date.issued2011
dc.identifier.issn1462-0324
dc.identifier.urihttps://doi.org/10.1093/rheumatology/keq324
dc.identifier.urihttp://hdl.handle.net/11655/14380
dc.description.abstractMethods. International experts have defined the inclusion criteria as follows: recurrent oral aphthosis (ROA) plus one of following-genital ulceration, erythema nodosum, folliculitis, pustulous/acneiform lesions, positive pathergy test, uveitis, venous/arterial thrombosis and family history of BD. Onset of disease is < 16 years, disease duration is 3 years, future follow-up duration is epsilon 4 years and informed consent is obtained. The expert committee has classified the included patients into: definite paediatric BD (PED-BD), probable PED-BD and no PED-BD. Statistical analysis is performed to compare the three groups of patients. Centres document their patients into a single database. Results. At January 2010, 110 patients (56 males/54 females) have been included. Mean age at first symptom: 8.1 years (median 8.2 years). At inclusion, 38% had only one symptom associated with ROA, 31% had two and 31% had three or more symptoms. A total of 106 first evaluations have been done. Seventeen patients underwent the first-year evaluation, and 36 had no new symptoms, 12 had one and 9 had two. Experts have examined 48 files and classified 30 as definite and 18 as probable. Twenty-six patients classified as definite fulfilled the International Study Group criteria. Seventeen patients classified as probable did not meet the international criteria. Conclusion. The expert committee has classified the majority of patients in the BD group although they presented with few symptoms independently of BD classification criteria.
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.isversionof10.1093/rheumatology/keq324
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatology
dc.titleRegistries in Rheumatological and Musculoskeletal Conditions. Paediatric Behcet'S Disease: An International Cohort Study of 110 Patients. One-Year Follow-Up Data
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRheumatology
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume50
dc.identifier.issue1
dc.identifier.startpage184
dc.identifier.endpage188
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster